| Issue |
Section |
Title |
File |
| Vol 84, No 8 (2012) |
Editorial |
Optimization of cell therapy in patients with inflammatory bowel diseases |
|
| Vol 84, No 12 (2012) |
Editorial |
Complete elimination of cytomegalovirus without antiviral therapy after systemic mesenchymal stromal cell transplantation in a patient with ulcerative colitis (a clinical case) |
|
| Vol 85, No 2 (2013) |
Editorial |
New possibilities for overcoming the secondary inefficiency of anti-cytokine therapy in patients with inflammatory bowel diseases |
|
| Vol 85, No 12 (2013) |
Editorial |
Immune response to biological therapy for inflammatory bowel diseases |
|
| Vol 86, No 2 (2014) |
Editorial |
Value of adhesion molecules for evaluating the efficiency of therapy for ulcerative colitis and Crohn's disease |
|
| Vol 86, No 2 (2014) |
Editorial |
Combination biological therapy for fistular Crohn's disease: Clinical demonstration |
|
| Vol 87, No 2 (2015) |
Editorial |
Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: Results of a 5-year follow-up |
|
| Vol 88, No 2 (2016) |
Editorial |
Use of mesenchymal stem cells in the combination therapy of ulcerative colitis |
(Rus)
|
| Vol 88, No 8 (2016) |
Editorial |
Long-term infliximab therapy for ulcerative colitis in real clinical practice |
(Rus)
|
| Vol 89, No 2 (2017) |
Editorial |
Efficacy of adalimumab for Crohn’s disease in real clinical practice |
(Rus)
|
